P

Inventor

BUCKMELTER ALEXANDRE JOSEPH

US31 patents
⚠️ This page may combine multiple inventors who share the name “BUCKMELTER ALEXANDRE JOSEPH”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

FORMA THERAPEUTICS INC

22 patents
US10377773B2Aug 13, 2019

Isothiazolopyrimidinones, pyrazolopyrimidinones, and pyrrolopyrimidinones as ubiquitin-specific protease 7 inhibitors

FORMA THERAPEUTICS INC18 citations94
US10377767B2Aug 13, 2019

Thienopyrimidinones as ubiquitin-specific protease 7 inhibitors

FORMA THERAPEUTICS INC16 citations94
US10351571B2Jul 16, 2019

Pyrrolotriazinones and imidazotriazinones as ubiquitin-specific protease 7 inhibitors

FORMA THERAPEUTICS INC15 citations94
US10000495B2Jun 19, 2018

Pyrrolotriazinones and imidazotriazinones as ubiquitin-specific protease 7 inhibitors

FORMA THERAPEUTICS INC21 citations94
US9938300B2Apr 10, 2018

Isothiazolopyrimidinones, pyrazolopyrimidinones, and pyrrolopyrimidinones as ubiquitin-specific protease 7 inhibitors

FORMA THERAPEUTICS INC23 citations94
US9840491B2Dec 12, 2017

Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors

FORMA THERAPEUTICS INC22 citations94
US10377760B2Aug 13, 2019

Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors

FORMA THERAPEUTICS INC17 citations93
US9902728B2Feb 27, 2018

Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors

FORMA THERAPEUTICS INC24 citations93
US10513507B2Dec 24, 2019

Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors

FORMA THERAPEUTICS INC9 citations92
US9932351B2Apr 3, 2018

Thienopyrimidinones as ubiquitin-specific protease 7 inhibitors

FORMA THERAPEUTICS INC24 citations92
US10519129B2Dec 31, 2019

Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors

FORMA THERAPEUTICS INC8 citations84
US10519128B2Dec 31, 2019

Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors

FORMA THERAPEUTICS INC8 citations84
US10519130B2Dec 31, 2019

Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors

FORMA THERAPEUTICS INC8 citations84
US10519127B2Dec 31, 2019

Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors

FORMA THERAPEUTICS INC8 citations84
US10513508B2Dec 24, 2019

Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors

FORMA THERAPEUTICS INC8 citations84
US10508098B2Dec 17, 2019

Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors

FORMA THERAPEUTICS INC8 citations84
US11161848B2Nov 2, 2021

Purinones as ubiquitin-specific protease 1 inhibitors

FORMA THERAPEUTICS INC1 citations73
US10399980B2Sep 3, 2019

Purinones as ubiquitin-specific protease 1 inhibitors

FORMA THERAPEUTICS INC2 citations73
US10189841B2Jan 29, 2019

Purinones as ubiquitin-specific protease 1 inhibitors

FORMA THERAPEUTICS INC3 citations73
US11247987B2Feb 15, 2022

Inhibiting ubiquitin specific peptidase 30

FORMA THERAPEUTICS INC3 citations71
US12043623B2Jul 23, 2024

Purinones as ubiquitin-specific protease 1 inhibitors

FORMA THERAPEUTICS INC0 citations62
US12049466B2Jul 30, 2024

Fused bicyclic compounds useful as ubiquitin-specific peptidase 30 inhibitors

FORMA THERAPEUTICS INC0 citations52

VALO EARLY DISCOVERY INC

6 patents

VALO HEALTH INC

2 patents

FORMA TM LLC

1 patent